|
[1]
|
Donovan, C., Arenas, E., Ayyala, R.S., et al. (2022) Fungal Keratitis: Mechanisms of Infection and Management Strategies. Survey of Ophthalmology, 67, 758-769. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Jiang, N., Zhao, G., Lin, J., Hu, L., et al. (2015) Indoleamine 2,3-Dioxygenase Is Involved in the Inflammation Response of Corneal Epithelial Cells to Aspergillus fumigatus Infections. PLOS ONE, 10, e0137423. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Hoffman, J.J., Burton, M.J. and Leck, A. (2021) Mycotic Keratitis—A Global Threat from the Filamentous Fungi. Journal of Fungi, 7, Article 273. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Liu, X., Sui, J., Li, C., et al. (2023) The Preparation and Therapeutic Effects of β-Glucan-Specific Nanobodies and Nanobody-Natamycin Conjugates in Fungal Keratitis. Acta Biomaterialia, 169, 398-409. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Yang, H., Wang, Q., Han, L., et al. (2020) Nerolidol Inhibits the LOX-1/IL-1β Signaling to Protect against the Aspergillus fumigatus Keratitis Inflammation Damage to the Cornea. International Immunopharmacology, 80, Article 106118. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Wang, Y., Yin, M., Gu, L., et al. (2023) The Therapeutic Role and Mechanism of 4-Methoxycinnamic Acid in Fungal Keratitis. International Immunopharmacology, 116, Article 109782. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Austin, A., Lietman, T. and Rose-Nussbaumer, J. (2017) Update on the Management of Infectious Keratitis. Ophthalmology, 124, 1678-1689. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Luan, S., Peng, X., Lin, J., et al. (2022) Gallic Acid Ameliorates Aspergillus fumigatus Keratitis through Reducing Fungal Load and Suppressing the Inflammatory Response. Investigative Ophthalmology & Visual Science, 63, 12. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Lakhani, P., Patil, A. and Majumdar, S. (2019) Challenges in the Polyene-and Azole-Based Pharmacotherapy of Ocular Fungal Infections. Journal of Ocular Pharmacology and Therapeutics, 35, 6-22. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Huang, Y., Gao, X. and Chen, J. (2018) Leukocyte-Derived Biomimetic Nanoparticulate Drug Delivery Systems for Cancer Therapy. Acta Pharmaceutica Sinica B, 8, 4-13. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Ihler, G.M., Glew, R.H. and Schnure, F.W. (1973) Enzyme Loading of Erythrocytes. Proceedings of the National Academy of Sciences, 70, 2663-2666. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Xia, Q., Zhang, Y., Li, Z., et al. (2019) Red Blood Cell Membrane-Camouflaged Nanoparticles: A Novel Drug Delivery System for Antitumor Application. Acta Pharmaceutica Sinica B, 9, 675-689. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Yu, H., Yan, J., Li, Z., et al. (2023) Enhanced Photothermal-Ferroptosis Effects Based on RBCm-Coated PDA Nanoparticles for Effective Cancer Therapy. Journal of Materials Chemistry B, 11, 415-429. [Google Scholar] [CrossRef]
|
|
[14]
|
McCall, R.L. and Sirianni, R.W. (2013) PLGA Nanoparticles Formed by Single-or Double-Emulsion with Vitamin E-TPGS. Journal of Visualized Experiments, 82, Article 51015. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Alshamsan, A. (2014) Nanoprecipitation Is More Efficient than Emulsion Solvent Evaporation Method to Encapsulate Cucurbitacin I in PLGA Nanoparticles. Saudi Pharmaceutical Journal, 22, 219-222. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Zhang, Z., Qian, H., Yang, M., et al. (2017) Gambogic Acid-Loaded Biomimetic Nanoparticles in Colorectal Cancer Treatment. International Journal of Nanomedicine, 12, 1593-1605. [Google Scholar] [CrossRef]
|
|
[17]
|
Wu, X., Li, Y., Raza, F., et al. (2021) Red Blood Cell Membrane-Camouflaged Tedizolid Phosphate-Loaded PLGA Nanoparticles for Bacterial-Infection Therapy. Pharmaceutics, 13, Article 99. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Liu, X., You, J., Peng, X., et al. (2020) Mammalian Ste20-Like Kinase 4 Inhibits the Inflammatory Response in Aspergillus fumigatus Keratitis. International Immunopharmacology, 88, Article 107021. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Brown, L., Leck, A.K., Gichangi, M., et al. (2021) The Global Incidence and Diagnosis of Fungal Keratitis. The Lancet Infectious Diseases, 21, E49-E57. [Google Scholar] [CrossRef]
|
|
[20]
|
Whitcher, J.P., Srinivasan, M. and Upadhyay, M.P. (2001) Corneal Blindness: A Global Perspective. Bulletin of the World Health Organization, 79, 214-221.
|
|
[21]
|
Sharma, N., Bagga, B., Singhal, D., et al. (2022) Fungal Keratitis: A Review of Clinical Presentations, Treatment Strategies and Outcomes. The Ocular Surface, 24, 22-30. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Abbondante, S., Leal, S.M., Clark, H.L., et al. (2023) Immunity to Pathogenic Fungi in the Eye. Seminars in Immunology, 67, Article 101753. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Shukla, P.K., Kumar, M. and Keshava, G.B. (2008) Mycotic Keratitis: An Overview of Diagnosis and Therapy. Mycoses, 51, 183-199. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Kimakura, M., Usui, T., Yokoo, S., et al. (2014) Toxicity of Topical Antifungal Agents to Stratified Human Cultivated Corneal Epithelial Sheets. Journal of Ocular Pharmacology and Therapeutics, 30, 810-814. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Niu, Y., Zhao, G., Li, C., et al. (2018) Aspergillus fumigatus Increased PAR-2 Expression and Elevated Proinflammatory Cytokines Expression through the Pathway of PAR-2/ERK1/2 in Cornea. Investigative Ophthalmology & Visual Science, 59, 166-175. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Su, J., Liu, G., Lian, Y., et al. (2018) Preparation and Characterization of Erythrocyte Membrane Cloaked PLGA/ Arsenic Trioxide Nanoparticles and Evaluation of Their in Vitro Anti-Tumor Effect. RSC Advances, 8, 20068-20076. [Google Scholar] [CrossRef]
|
|
[27]
|
Mills, B., Radhakrishnan, N., Karthikeyan Rajapandian, S.G., et al. (2021) The Role of Fungi in Fungal Keratitis. Experimental Eye Research, 202, Article 108372. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Yang, R.-B., Wu, L.-P., Lu, X.-X., et al. (2021) Immunologic Mechanism of Fungal Keratitis. International Journal of Ophthalmology, 14, 1100-1106. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Espinosa, V., Dutta, O., Mcelrath, C., et al. (2017) Type III Interferon Is a Critical Regulator of Innate Antifungal Immunity. Science Immunology, 2, eaan5357. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Fortingo, N., Melnyk, S., Sutton, S.H., et al. (2022) Innate Immune System Activation, Inflammation and Corneal Wound Healing. International Journal of Molecular Sciences, 23, Article 14933. [Google Scholar] [CrossRef] [PubMed]
|